1-11 of 11
Al B. Benson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11

Vered Stearns, Opeyemi A. Jegede, Victor T.-S. Chang, Todd C. Skaar, Jeffrey L. Berenberg, Ranveer Nand, Atif Shafqat, Nisha L. Jacobs, William Luginbuhl, Paul Gilman, Al B. Benson, III, Judie R. Goodman, Gary L. Buchschacher, Jr, N. Lynn Henry, Charles L. Loprinzi, Patrick J. Flynn, Edith P. Mitchell, Michael J. Fisch, Joseph A. Sparano, Lynne I. Wagner
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (13): 2709–2718.
https://doi.org/10.1158/1078-0432.CCR-23-2137
Published: 01 July 2024
View article titled, A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11
Open the PDF for A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11 in another window
Includes: Supplementary data
Journal Articles

Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors

Anna M. Varghese, Dana B. Cardin, Jonathan Hersch, Al B. Benson, Howard S. Hochster, Lukas Makris, Kensuke Hamada, Jordan D. Berlin, Leonard B. Saltz
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (7): 1555–1562.
https://doi.org/10.1158/1078-0432.CCR-19-2743
Published: 01 April 2020
View article titled, Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors
Open the PDF for Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors in another window
Includes: Supplementary data
Journal Articles

BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer

Al B. Benson, III, Igor Kiss, John Bridgewater, Ferry A.L.M. Eskens, Carolyn Sasse, Sandra Vossen, Jihong Chen, Chip Van Sant, Howard A. Ball, Anne Keating, Andrew Krivoshik
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (20): 5058–5067.
https://doi.org/10.1158/1078-0432.CCR-15-3117
Published: 13 October 2016
View article titled, BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer
Open the PDF for BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation

Pierre Bohanes, Cathryn J. Rankin, Charles D. Blanke, Thomas Winder, Cornelia M. Ulrich, Stephen R. Smalley, Tyvin A. Rich, James A. Martensen, Al B. Benson, III, Robert J. Mayer, Christine M. Cripps, Kathleen Danenberg, Karen W. Makar, Wu Zhang, Jacqueline K. Benedetti, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (7): 1583–1590.
https://doi.org/10.1158/1078-0432.CCR-14-0857
Published: 31 March 2015
View article titled, Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation
Open the PDF for Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation in another window
Journal Articles

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

Shuji Ogino, Kaori Shima, Jeffrey A. Meyerhardt, Nadine J. McCleary, Kimmie Ng, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, Paul Schaefer, Renaud Whittom, Alexander Hantel, Al B. Benson, III, Donna Spiegelman, Richard M. Goldberg, Monica M. Bertagnolli, Charles S. Fuchs
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3): 890–900.
https://doi.org/10.1158/1078-0432.CCR-11-2246
Published: 31 January 2012
View article titled, Predictive and Prognostic Roles of <em>BRAF</em> Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
Open the PDF for Predictive and Prognostic Roles of <em>BRAF</em> Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803 in another window
Includes: Supplementary data
Journal Articles

KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803

Shuji Ogino, Jeffrey A. Meyerhardt, Natsumi Irahara, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, Paul Schaefer, Renaud Whittom, Alexander Hantel, Al B. Benson, III, Richard M. Goldberg, Monica M. Bertagnolli, Charles S. Fuchs, for the Cancer and Leukemia Group B, North Central Cancer Treatment Group, Canadian Cancer Society Research Institute, Southwest Oncology Group
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7322–7329.
https://doi.org/10.1158/1078-0432.CCR-09-1570
Published: 30 November 2009
View article titled, <em>KRAS</em> Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803
Open the PDF for <em>KRAS</em> Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803 in another window
Journal Articles

Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer

Howard L. Kaufman, Heinz-Josef Lenz, John Marshall, Deepti Singh, Chris Garett, Christine Cripps, Malcolm Moore, Margaret von Mehren, Richard Dalfen, William J. Heim, Robert M. Conry, Walter J. Urba, Al B. Benson, III, Maria Yu, Judy Caterini, Seunghee Kim-Schulze, Mark DeBenedette, Danielle Salha, Thorsten Vogel, Ileana Elias, Neil L. Berinstein
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (15): 4843–4849.
https://doi.org/10.1158/1078-0432.CCR-08-0276
Published: 01 August 2008
View article titled, Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer
Open the PDF for Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer in another window
Journal Articles

New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancer: Summary Statement from 2007 Santa Monica Conference

Lee S. Rosen, Anton J. Bilchik, Robert W. Beart, Jr., Al B. Benson, III, Kenneth J. Chang, Carolyn C. Compton, Axel Grothey, Daniel G. Haller, Clifford Y. Ko, Patrick M. Lynch, Heidi Nelson, Michael J. Stamos, Roderick R. Turner, Christopher G. Willett
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22): 6853s–6856s.
https://doi.org/10.1158/1078-0432.CCR-07-1629
Published: 15 November 2007
View article titled, New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancer: Summary Statement from 2007 Santa Monica Conference
Open the PDF for New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancer: Summary Statement from 2007 Santa Monica Conference in another window
Journal Articles

New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancers: Cooperative Group Strategies for Assessing Optimal Approaches in Early-Stage Disease

Al B. Benson, III
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22): 6913s–6920s.
https://doi.org/10.1158/1078-0432.CCR-07-1188
Published: 15 November 2007
View article titled, New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancers: Cooperative Group Strategies for Assessing Optimal Approaches in Early-Stage Disease
Open the PDF for New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancers: Cooperative Group Strategies for Assessing Optimal Approaches in Early-Stage Disease in another window
Journal Articles

Association between DNA Methylation and Shortened Survival in Patients with Advanced Colorectal Cancer Treated with 5-Fluorouracil–Based Chemotherapy

Lanlan Shen, Paul J. Catalano, Al B. Benson, III, Peter O'Dwyer, Stanley R. Hamilton, Jean-Pierre J. Issa
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (20): 6093–6098.
https://doi.org/10.1158/1078-0432.CCR-07-1011
Published: 18 October 2007
View article titled, Association between DNA Methylation and Shortened Survival in Patients with Advanced Colorectal Cancer Treated with 5-Fluorouracil–Based Chemotherapy
Open the PDF for Association between DNA Methylation and Shortened Survival in Patients with Advanced Colorectal Cancer Treated with 5-Fluorouracil–Based Chemotherapy in another window
Journal Articles

Chronic Daily Low Dose of 4-Methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in Patients with Previously Resected Colon Polyps and First-Degree Female Relatives of Breast Cancer Patients

Al B. Benson, III, Olufunmilayo I. Olopade, Mark J. Ratain, Alfred Rademaker, Sohrab Mobarhan, Lisa Stucky-Marshall, Suzanne French, M. Eileen Dolan
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (10): 3870–3877.
Published: 01 October 2000
View article titled, Chronic Daily Low Dose of 4-Methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in Patients with Previously Resected Colon Polyps and First-Degree Female Relatives of Breast Cancer Patients
Open the PDF for Chronic Daily Low Dose of 4-Methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in Patients with Previously Resected Colon Polyps and First-Degree Female Relatives of Breast Cancer Patients in another window